Molecular Imaging Using Radiolabeled Atezolizumab to Assess Atezolizumab Biodistribution in Lymphoma Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03850028 |
|
Recruitment Status :
Recruiting
First Posted : February 21, 2019
Last Update Posted : June 18, 2019
|
Sponsor:
University Medical Center Groningen
Collaborators:
Amsterdam UMC, location VUmc
Stichting Hemato-Oncologie voor Volwassenen Nederland
Hoffmann-La Roche
Information provided by (Responsible Party):
Marcel Nijland, University Medical Center Groningen
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | April 2, 2025 |
| Estimated Study Completion Date : | April 2, 2025 |